| Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program WC Moore, DA Meyers, SE Wenzel, WG Teague, H Li, X Li, ... American journal of respiratory and critical care medicine 181 (4), 315-323, 2010 | 2572 | 2010 |
| Treatment of asthma with drugs modifying the leukotriene pathway JM Drazen, E Israel, PM O'Byrne New England Journal of Medicine 340 (3), 197-206, 1999 | 1165 | 1999 |
| Characterization of the severe asthma phenotype by the national heart, lung, and blood institute's severe asthma research program WC Moore, ER Bleecker, D Curran-Everett, SC Erzurum, BT Ameredes, ... Journal of Allergy and Clinical Immunology 119 (2), 405-413, 2007 | 1038 | 2007 |
| Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations Children's Health Study (CHS) and HARBORS study Gilliland Frank D 4, ... Nature genetics 43 (9), 887-892, 2011 | 933 | 2011 |
| Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial M Castro, AS Rubin, M Laviolette, J Fiterman, M De Andrade Lima, ... American journal of respiratory and critical care medicine 181 (2), 116-124, 2010 | 913 | 2010 |
| Significant variability in response to inhaled corticosteroids for persistent asthma SJ Szefler, RJ Martin, TS King, HA Boushey, RM Cherniack, VM Chinchilli, ... Journal of Allergy and Clinical Immunology 109 (3), 410-418, 2002 | 742 | 2002 |
| Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment JM Drazen, CN Yandava, L Dubé, N Szczerback, R Hippensteel, A Pillari, ... Nature genetics 22 (2), 168-170, 1999 | 742 | 1999 |
| Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial E Israel, VM Chinchilli, JG Ford, HA Boushey, R Cherniack, TJ Craig, ... The Lancet 364 (9444), 1505-1512, 2004 | 738 | 2004 |
| Tiotropium bromide step-up therapy for adults with uncontrolled asthma SP Peters, SJ Kunselman, N Icitovic, WC Moore, R Pascual, BT Ameredes, ... New England Journal of Medicine 363 (18), 1715-1726, 2010 | 715 | 2010 |
| The Effect of Polymorphisms of the β2-Adrenergic Receptor on the Response to Regular Use of Albuterol in Asthma E Israel, JM Drazen, SB Liggett, HA Boushey, RM Cherniack, ... American journal of respiratory and critical care medicine 162 (1), 75-80, 2000 | 694 | 2000 |
| Interleukin-17–producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity HY Kim, HJ Lee, YJ Chang, M Pichavant, SA Shore, KA Fitzgerald, ... Nature medicine 20 (1), 54-61, 2014 | 672 | 2014 |
| Tezepelumab in adults and adolescents with severe, uncontrolled asthma A Menzies-Gow, J Corren, A Bourdin, G Chupp, E Israel, ME Wechsler, ... New England Journal of Medicine 384 (19), 1800-1809, 2021 | 627 | 2021 |
| Unjamming and cell shape in the asthmatic airway epithelium JA Park, JH Kim, D Bi, JA Mitchel, NT Qazvini, K Tantisira, CY Park, ... Nature materials 14 (10), 1040-1048, 2015 | 598 | 2015 |
| Severe and difficult-to-treat asthma in adults E Israel, HK Reddel New England Journal of Medicine 377 (10), 965-976, 2017 | 550 | 2017 |
| Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma SC Lazarus, VM Chinchilli, NJ Rollings, HA Boushey, R Cherniack, ... American journal of respiratory and critical care medicine 175 (8), 783-790, 2007 | 546 | 2007 |
| Daily versus as-needed corticosteroids for mild persistent asthma HA Boushey, CA Sorkness, TS King, SD Sullivan, JV Fahy, SC Lazarus, ... New England Journal of Medicine 352 (15), 1519-1528, 2005 | 540 | 2005 |
| COVID-19–related genes in sputum cells in asthma. Relationship to demographic features and corticosteroids MC Peters, S Sajuthi, P Deford, S Christenson, CL Rios, MT Montgomery, ... American journal of respiratory and critical care medicine 202 (1), 83-90, 2020 | 533 | 2020 |
| Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma C Barnig, M Cernadas, S Dutile, X Liu, MA Perrella, S Kazani, ... Science translational medicine 5 (174), 174ra26-174ra26, 2013 | 508 | 2013 |
| The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin E Israel, AR Fischer, MA Rosenberg, CM Lilly, JC Callery, J Shapiro, ... American Review of Respiratory Disease 148 (6_pt_1), 1447-1451, 1993 | 490 | 1993 |
| Obesity and asthma: an association modified by age of asthma onset F Holguin, ER Bleecker, WW Busse, WJ Calhoun, M Castro, SC Erzurum, ... Journal of Allergy and Clinical Immunology 127 (6), 1486-1493. e2, 2011 | 486 | 2011 |
